Veeda Clinical Research Unlisted Shares
Veeda Clinical Research Unlisted Shares Share Price
Industry research & developmentSector medicalDepository NSDL, CDSL
52W High
₹5,187.00
52W Low
₹467.25
1Y Return
-3.3%
Overview
About The Company
Deep Dive
Veeda Clinical Research Unlisted Shares Unlisted Shares
Financials · IPO timeline · Growth projects
Veeda Clinical Research Ltd. was established in 2004 by a team of experienced medical science professionals with a vision to set up a premium CRO known for its Independence, technical edge, scientific know-how, and better foresight for a clinical trial, an objective of becoming a catalyst for enhanced drug development.
Strong
Market Position
Consistent
YoY Growth
Experienced
Management
Fundamentals
Key Indicators
A snapshot of Veeda Clinical Research Unlisted Shares's financial health, valuation multiples and capital efficiency at a glance.
Current Share Price₹467.25
Face Value / Share₹2.00
Book Value / Share₹131.00
Price to Earning (PE)-44.20
Price / Sales4.90
Price / Book3.60
Outstanding Shares6.58Cr
Market Cap₹3,073.00Cr
Debt / Equity1.16
Dividend / Share₹0.00
Dividend %0.00%
Return on Total Assets-3%
Return on Equity-7%
Working Capital Return11%
Veeda Clinical Research Unlisted SharesNSDL, CDSL Unlisted Shares
₹467.25
Estimated total₹4,672.50
Settled in T+2 days · KYC verified dealers
Performance
Pricing Trends
6-Month Movement
₹467.25↗ +0.00 (+0.00%)
Financials
Financial Performance
| Indicators | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 621.1 | 293.0 | 311.3 | 293.1 | 234.3 |
| Expense | 484.7 | 247.4 | 247.0 | 209.8 | 129.1 |
| EBITDA | 136.4 | 45.6 | 64.3 | 83.3 | 105.2 |
| Other Cost | 202.0 | 40.9 | 28.8 | 17.7 | 20.0 |
| PBT | -65.5 | 4.7 | 35.5 | 65.6 | 85.2 |
| Tax Expense | 1.3 | 1.6 | 11.1 | 15.5 | 22.2 |
| PAT | -66.8 | 3.1 | 24.4 | 50.1 | 63.0 |
| Other Inc./Exp. | 8.4 | -0.1 | -0.4 | 0.3 | -0.1 |
| Net Income | -58.4 | 3.0 | 24.0 | 50.4 | 62.9 |
| Shares O/S | 6.58 | 6.30 | 3.60 | 3.60 | 3.60 |
| EPS (₹) | -10.57 | 0.50 | 7.60 | 10.30 | 15.40 |
| Rev. Growth % | 112.0% | -5.9% | 6.2% | 25.1% | — |
| EBITDA Mgn % | 22.0% | 15.6% | 20.7% | 28.4% | 44.9% |
| Net Mgn % | -9.4% | 1.0% | 7.7% | 17.2% | 26.8% |
| EPS Growth | -2214.0% | -93.4% | -26.2% | -33.1% | — |
Corporate
Registered Address
#
ISIN
INE01HQ01026
§
PAN
AACCC3633Q
Address
Shivalik Plaza – A, 2nd Floor, Opp. Ahmedabad Management Association, Ambawadi, Ahmedabad – 380015, Gujarat
RTA
link intime india pvt ltd
Leadership
Management Team
MB
Mahesh Bhalgat
CEO & Managing Director
NB
Nirmal Bhatia
Company Secretary & Chief Financial Officer
ND
Nitin Deshmukh
Chairman
Reports
Download Financial Results
📄Annual Report 2024
▼📅Select Year
▼Press
In The News
MC↗
Veeda Clinical Research: CX Partners-led consortium looks to sell majority stake
Jul 29, 2025Learn more →
BUSINESS-STANDARD↗
Veeda Clinical Research buys European CRO Heads for an undisclosed sum
Jul 29, 2025Learn more →
MC↗
Veeda Clinical Research appoints Mahesh Bhalgat as Group CEO
Jul 29, 2025Learn more →
THEHINDUBUSINESSLINE↗
Veeda Clinical Research acquires 50.1 per cent stake in Bioneeds
Jul 29, 2025Learn more →
MC↗
Veeda Clinical Research files DRHP for Rs 831.6 crore IPO
Jul 29, 2025Learn more →
Mint↗
Veeda Clinical raises $16 mn from Sabre partners, others
Jul 29, 2025Learn more →
ET↗
Veeda Clinical Research refiles DRHP for IPO with sebi
Jul 29, 2025Learn more →
Top Unlisted companies
Current Price: ₹ 11182.5/-
Current Price: ₹ 2756.25/-
Current Price: ₹ 50.4/-
Current Price: ₹ 8767.5/-
Current Price: ₹ 370.65/-
Current Price: ₹ 2703.75/-
Current Price: ₹ 2043.93/-
Current Price: ₹ 18637.5/-
Help
Frequently Asked Questions
?
Still have questions?
Our expert team typically responds within 30 minutes during market hours.
The company’s face value of shares is ₹2 per equity share. This is part of the Veeda Clinical Research IPO structure, which includes both a fresh issue of shares and an offer for sale.
